Literature DB >> 14713821

Botulinum toxin type B for type A resistant bladder spasticity.

D Pistolesi1, C Selli, B Rossi, G Stampacchia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713821     DOI: 10.1097/01.ju.0000108844.10235.f1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  11 in total

Review 1.  [Botulinum toxin in urology. Indications and results].

Authors:  B Schurch; A Reitz
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

2.  Botulinum Toxin Use in Neurourology.

Authors:  Benoit Peyronnet; Xavier Gamé; Gregory Vurture; Victor W Nitti; Benjamin M Brucker
Journal:  Rev Urol       Date:  2018

3.  Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art.

Authors:  Victor W Nitti
Journal:  Rev Urol       Date:  2006

Review 4.  Management of bladder, prostatic and pelvic floor disorders.

Authors:  G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 5.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 6.  Botulinum toxin for the management of bladder dysfunction.

Authors:  Brigitte Schurch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 7.  [Botulinum toxin for the treatment of overactive bladder--an overview].

Authors:  C Seif; S Boy; B Wefer; R Dmochowski; P M Braun; K-P Jünemann
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

Review 8.  Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution?

Authors:  Darius J Unwala; Paholo Barboglio; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

9.  Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study.

Authors:  Pamela Latino; Letizia Castelli; Luca Prosperini; Maria Rita Marchetti; Carlo Pozzilli; Morena Giovannelli
Journal:  Neurol Sci       Date:  2017-08-01       Impact factor: 3.307

10.  OnabotulinumtoxinA in the treatment of neurogenic bladder.

Authors:  Aziz Gulamhusein; Altaf Mangera
Journal:  Biologics       Date:  2012-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.